Skip to main content
. 2016 Oct 17;35(1):24–31. doi: 10.1200/JCO.2016.68.2740

Fig 2.

Fig 2.

Graphs of overall survival and progression-free survival after autologous stem-cell transplantation in patients with DHL compared with patients without DHL. (A) Overall survival. (B) Progression-free survival. (C) Progression-free survival in patients with DHL compared with patients with DEL without DHL and patients with neither DEL nor DHL. (D). Progression-free survival curves adjusted for baseline covariates, stratifying patients by disease status into nonDEL/nonDHL (n = 58), DEL/nonDHL (n = 47), nonDEL/DHL (n = 7), and DEL/DHL (n = 5). DEL, double-expressor lymphoma; DHL, double-hit lymphoma.